Mucoadhesive carriers for oral drug delivery

R Kumar, T Islam, M Nurunnabi - Journal of Controlled Release, 2022 - Elsevier
Among the various dosage forms, oral medicine has extensive benefits including ease of
administration and patients' compliance, over injectable, suppositories, ocular and nasal …

Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis: JACC: CardioOncology State-of-the-Art Review

O Leiva, D AbdelHameid, JM Connors, CP Cannon… - Cardio Oncology, 2021 - jacc.org
Cardiovascular disease and cancer are the 2 leading causes of death worldwide. Emerging
evidence suggests common mechanisms between cancer and cardiovascular disease …

Risk factors for the diagnosis of colorectal cancer

A Lewandowska, G Rudzki, T Lewandowski… - Cancer …, 2022 - journals.sagepub.com
Background Colorectal cancer defined as cancer of the colon or rectum, is the third most
frequently diagnosed cancer in men and the second in women, and, according to the World …

The increasing incidence of young-onset colorectal cancer: a call to action

DJ Ahnen, SW Wade, WF Jones, R Sifri… - Mayo Clinic …, 2014 - Elsevier
Abstract In the United States, colorectal cancer (CRC) is the third most common and second
most lethal cancer. More than one-tenth of CRC cases (11% of colon cancers and 18% of …

Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms

B Arcidiacono, S Iiritano, A Nocera… - Journal of Diabetes …, 2012 - Wiley Online Library
Insulin resistance is common in individuals with obesity or type 2 diabetes (T2D), in which
circulating insulin levels are frequently increased. Recent epidemiological and clinical …

Colorectal cancer in the young

SG Patel, DJ Ahnen - Current gastroenterology reports, 2018 - Springer
Abstract Purpose of Review Colorectal cancer incidence has been rapidly rising in those
under the age of 50 over the last 20 years. This paper will review the epidemiology …

Early colorectal cancer: diagnosis, treatment and survivorship care

G Buccafusca, I Proserpio, AC Tralongo… - Critical reviews in …, 2019 - Elsevier
CRC is the third most commonly diagnosed malignancy and the fourth leading cause of
cancer-related death in the world. With advances in treatment, colorectal cancer is being …

Meta-analysis of altered gut microbiota reveals microbial and metabolic biomarkers for colorectal cancer

N Avuthu, C Guda - Microbiology Spectrum, 2022 - Am Soc Microbiol
Colorectal cancer (CRC) is the second leading cause of cancer mortality worldwide. The
dysbiotic gut microbiota and its metabolite secretions play a significant role in CRC …

The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment

LC Connell, JM Mota, MI Braghiroli, PM Hoff - Current treatment options in …, 2017 - Springer
Opinion statement Colorectal cancer (CRC) is the third leading cancer diagnosed globally
and an important cause of cancer-related mortality. Of interest, while we have witnessed a …

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years

FER Vuik, SAV Nieuwenburg, M Bardou… - Gut, 2019 - gut.bmj.com
Objective The incidence of colorectal cancer (CRC) declines among subjects aged 50 years
and above. An opposite trend appears among younger adults. In Europe, data on CRC …